ORION Biotech Catalyst Calendar
Menu
Skip to company history
COMPANY HISTORY / RETAINED ORIGINAL SOURCES

What did the company say,
and what came next?

In the reviewed release recorded , ORION retains 2 historical announcement records as of for Gilead Sciences (GILD). Read the original sources and their publication dates below or inspect the dated catalog.

Last updated: · reviewed catalog release, not a fresh source check

  1. 1 Choose one ticker
  2. 2 Read the evidence
  3. 3 Keep a starting point

10 companies · 24 retained records · Reviewed 2026-09-26T07:20:44Z.

What did GILD disclose about Lenacapavir?

Gilead Sciences · PURPOSE 1 Phase 3 update · 2 retained source records as of .

Earlier selected statement

Read the source context →

Stated timing: Second half of 2024

Source published · Original announcement. ORION first recorded .

Later selected disclosure

Read the source context →

Source published · Original announcement. ORION first recorded .

Follow-up research question

Was this an interim analysis or final readout, and which population and comparator were studied?

YOUR PRIVATE STARTING POINT

Compare with what you saved.

Save a milestone to your account’s Notebook. Reopen its original snapshot here and compare with this reviewed catalog. Email subscriptions use a separate opt-in.

Sign inManage Notebook allowance
Source index · readable without the interactive view

Gilead Sciences (GILD)

PURPOSE 1 Phase 3 update

  1. Q4 2023 prepared remarks: PURPOSE 1 timing

    Gilead expected a Phase 3 PURPOSE 1 update in the second half of 2024. The presentation described timing estimates, not a guaranteed efficacy outcome.

    Stated timing: Second half of 2024

    Original announcement.

    Source published (published_at)
    Event effective (effective_at)
    UNAVAILABLE
    ORION first seen (first_seen_at)
    ORION ingested (ingested_at)
  2. PURPOSE 1 interim topline announcement

    Gilead published results from a PURPOSE 1 interim analysis and reported a committee recommendation to stop the blinded phase. This interim announcement was earlier than the previously indicated update window; it was not final regulatory approval.

    Original announcement.

    Source published (published_at)
    Event effective (effective_at)
    ORION first seen (first_seen_at)
    ORION ingested (ingested_at)

Scope

These selected company announcements preserve publication dates separately from ORION’s later recording times. Registry completion dates and follow-up research questions are separate from company announcements; this historical release does not establish current guidance or continuous monitoring.

Coverage & method → · Corrections · Catalog manifest

THE WEEKLY RESEARCH NOTE

Keep the original sources close.

Sign up for ORION’s free English research email. Company-specific monitoring is separate.

Checking email signup availability…